THE GUT INSTINCT
THE TWIN BRAINS
A SINGLE SOLUTION

Decoding the Gut-Brain Axis with AI to Develop Precision
Medicines for Gastrointestinal and Hepatobiliary Disorders

Invea Therapeutics, Inc. (Invea) is at the forefront of applying artificial intelligence (AI) to develop transformational precision medicines for highly debilitating gastrointestinal and hepatobiliary disorders. We use a differentiated approach that leverages a first-of-its-kind AI platform to decode the gut-brain axis.

We are excited about the potential of our team, approach, and AI platform to transform the treatment paradigm and ultimately the quality of life for patients whose medical needs remain unresolved with current treatment options.

Invea Therapeutics, Inc. (Invea) is at the forefront of applying artificial intelligence (AI) to develop transformational precision medicines for highly debilitating gastrointestinal and hepatobiliary disorders. We use a differentiated approach that leverages a first-of-its-kind AI platform to decode the gut-brain axis.

We are excited about the potential of our team, approach, and AI platform to transform the treatment paradigm and ultimately the quality of life for patients whose medical needs remain unresolved with current treatment options.

The Company

Decoding the Gut-Brain Axis with the Power of Artificial Intelligence

At Invea, we are expediting the discovery and development of transformational precision medicines for disorders impacted by the gut-brain axis (GBA). The Company is harnessing the power of AI to decode the underlying biology and critical components of the GBA such as innate immunity, inflammasome biology, and neuroinflammation to ensure a precision medicine approach and an increased probability of clinical success.

Know More

The Science

“TRUST YOUR GUT!”

This is not an abstraction. The gut and the brain are in constant communication, linking physiology to psychology. This communication path– The Gut-Brain Axis (GBA) –monitors and integrates gut functions with the emotional and cognitive centers of the brain. When dysregulated, the GBA has been linked to many debilitating disorders.

Know More

The Technology

Leveraging Artificial Intelligence to Accelerate and Enhance Target and Drug Discovery Innovation

Invea is dedicated to identifying, researching, and developing treatment options that will create a lasting impact on patients around the world. We have built a unique AI-driven platform that addresses unmet medical needs by integrating various types of data underlying biology, symptomatology, and pharmacology to expedite and de-risk drug discovery and development.

Know More